Leuprolide acetate-induced leukocytoclastic vasculitis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 7, 2007, Pages 892-893

  Turk, Bengu Gerceker ^a   Dereli, Tugrul ^a   Dereli, Didem ^b   Akalin, Taner ^a  

^a EGE UNIVERSITY   (Turkey)

^b Ege Saglik Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LEUPRORELIN; LUCRIN DEPOT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; ECCHYMOSIS; ENDOMETRIOSIS; FEMALE; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; PETECHIA; PRIORITY JOURNAL; PURPURIC RASH; SKIN BIOPSY; SKIN EXAMINATION;

ADULT; FEMALE; HUMANS; LEUPROLIDE; VASCULITIS, HYPERSENSITIVITY;

EID: 34447132320     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600608717     Document Type: Article

References (5)

1. Crowson AN, Mihm MC Jr, Magro CM. Cutaneous vasculitis: areview. J Cutan Pathol. 2003;30:161-73.
2. TAP Pharmaceuticals. New drug application. Lupron depot 3.75 mg: for the management of endometriosis. Deerfield, IL: TAP Pharmaceuticals, 1991.
3. Davidson KA, Ringpfeil F, Lee JB. Ibuprophen-induced bullousleukocytoclastic vasculitis. Cutis. 2001;67:303-10.
4. Cobeta-Garcia JC, Garcia-Enguita P, Pina-Latorre MA, Lerin-Sanchez FJ, Rodilla-Calvelo F. Ritodrine-induced leukocytoclastic vasculitis in pregnancy. Ann Pharmacother. 2004;38:66-9.
5. Whitaker IS, Fazel MZ, Joshi HB, Moseley RP, Turner WH. Leuprorelin acetate granulomas: recurrent subcutaneous nodules mimicking metastatic deposits at injection sites. BJU Int. 2002;90:350.